ABDXF (Abingdon Health) Cash Flow from Others: $-0.02 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ABDXF Abingdon Health PLC ABDXF
49 GF Score
Price $0.15
GF Value $0.23
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Abingdon Health Cash Flow from Others?

Abingdon Health ABDXF 49 Cash Flow from Others is $-0.02 Mil as of Dec. 2025. GuruFocus rates ABDXF with a GF Score™ of 49/100 and a GF Value™ of $0.23 (Possible Value Trap). The stock has 7 warning signs investors should review.

Abingdon Health's cash flow from others for the six months ended in Dec. 2025 was $-0.27 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.02 Mil.

Abingdon Health Cash Flow from Others Related Terms

Abingdon Health Cash Flow from Others Historical Data

* Premium members only.

The historical data trend for Abingdon Health's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abingdon Health Cash Flow from Others Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Flow from Others
Get a 7-Day Free Trial 0.20 21.36 0.13 0.01 0.05

Abingdon Health Semi-Annual Data
Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.85 0.86 -0.19 0.25 -0.27
ABDXF
49GF Score
Abingdon Health PLC ABDXF
Cash Flow from Others is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abingdon Health Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.02 Mil.

Frequently Asked Questions Learn more about Cash Flow from Others →
What does a Cash Flow from Others of $-0.02 Mil mean?
Abingdon Health (ABDXF) has a Cash Flow from Others of $-0.02 Mil as of Dec. 2025. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Abingdon Health and its competitors.
Is Abingdon Health's Cash Flow from Others too high?
Abingdon Health's current Cash Flow from Others is $-0.02 Mil. Overall, Abingdon Health has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Abingdon Health's Cash Flow from Others compare to TMO and DHR?
Abingdon Health's Cash Flow from Others of $-0.02 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Others for a Medical Diagnostics & Research company?
A good Cash Flow from Others depends on the Medical Diagnostics & Research industry context. However, Cash Flow from Others should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Others mean?
A high Cash Flow from Others can signal that a stock is expensive relative to its fundamentals. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Abingdon Health and its competitors. Abingdon Health's current Cash Flow from Others is $-0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abingdon Health stock overvalued right now?
Based on GuruFocus' analysis, Abingdon Health (ABDXF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.23, compared to a current price of $0.15 — trading 34.8% below its estimated fair value. The current Cash Flow from Others is $-0.02 Mil. Abingdon Health's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Others calculated?
Cash Flow from Others is calculated from a company's financial statements. For Abingdon Health (ABDXF), the current Cash Flow from Others is $-0.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abingdon Health (ABDXF) Overvalued in 2026?

Based on GuruFocus' analysis, Abingdon Health stock appears to be undervalued. The current stock price of $0.15 is trading 34.8% below its estimated GF Value™ of $0.23. GuruFocus considers Abingdon Health to be Possible Value Trap.

Key valuation signals for ABDXF:

  • Cash Flow from Others: $-0.02 Mil
  • GF Value™: $0.23 vs. price of $0.15 (34.8% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ABDXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abingdon Health Business Description

Other Exchanges ABDX:UK
Address York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
49GF Score

Get the complete analysis for ABDXF

Cash Flow from Others is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.23
GF Value